1. Home
  2. TRTX vs EOLS Comparison

TRTX vs EOLS Comparison

Compare TRTX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

N/A

Current Price

$7.78

Market Cap

660.2M

Sector

Real Estate

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$9.07

Market Cap

550.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRTX
EOLS
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
660.2M
550.9M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
TRTX
EOLS
Price
$7.78
$9.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$9.83
$15.50
AVG Volume (30 Days)
773.7K
1.1M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
11.55%
N/A
EPS Growth
N/A
1.23
EPS
0.19
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$8.78
$13.27
Revenue Next Year
$4.14
$17.62
P/E Ratio
$41.05
N/A
Revenue Growth
N/A
11.61
52 Week Low
$7.57
$3.86
52 Week High
$9.85
$9.15

Technical Indicators

Market Signals
Indicator
TRTX
EOLS
Relative Strength Index (RSI) 45.60 69.65
Support Level $7.57 $6.39
Resistance Level $8.74 N/A
Average True Range (ATR) 0.12 0.35
MACD 0.02 0.00
Stochastic Oscillator 51.28 90.91

Price Performance

Historical Comparison
TRTX
EOLS

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: